Patent · US Active

Method for producing an intermediate product of dabigatran etexilate

US8471033B2 · kind B2 · utility

4Cited by

3References

5Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Christian Filser · Bodenheim, DE
Wolfgang Dersch · Ingelheim am Rhein, DE
Rainer Hamm · Ingelheim am Rhein, DE
Arndt Hausherr · Mainz, DE
Gunter Koch · Bad Kreuznach, DE
Ulrich Scholz · Bad Hersfeld, DE
Georg Zerban · Ingelheim am Rhein, DE

Key dates

Filing date	Jun 12, 2009
Grant date	Jun 25, 2013
Priority date	—
Expiry date	Jan 9, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention relates to a process for preparing the compound of formula 1a valuable intermediate product in the synthesis of the pharmaceutical active substance dabigatran etexilate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.